{"name": "PhaseBio Pharmaceuticals",
 "permalink": "phasebio-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/phasebio-pharmaceuticals",
 "homepage_url": "http://www.phasebio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "610-981-6500",
 "description": "",
 "created_at": "Fri Jan 08 04:35:44 UTC 2010",
 "updated_at": "Wed Mar 27 11:50:07 UTC 2013",
 "overview": "\u003Cp\u003EPhaseBio is a clinical-stage biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. The company uses its proprietary recombinant biopolymers called elastin-like polypeptides (ELPs) to improve the stability, bioavailability, activity and ease of administration of proteins and peptides, with the goal of achieving greater potency, fewer side effects and better patient compliance. Efficient production in E. coli ensures low cost of goods.\u003C/p\u003E\n\n\u003Cp\u003EPhaseBio\u2019s lead drug candidate, PB1023, is currently being evaluated in a phase 2b clinical trial for the treatment of hyperglycemia associated with type 2 diabetes, with potential for future use in the treatment of obesity. Our second drug candidate, Vasomera\u2122, is currently being evaluated in a phase 1 clinical trial and has exciting potential for use in the treatment of pulmonary arterial hypertension (PAH) and heart failure. Our third program, Insumera, a basal insulin based on native human insulin, will enter clinical trials in early 2013.\u003C/p\u003E\n\n\u003Cp\u003EPhaseBio is based in Malvern, Pennsylvania..\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       49],
      "assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],
     [[193,
       64],
      "assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],
     [[193,
       64],
      "assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Christopher",
      "last_name": "Prior",
      "permalink": "christopher-prior",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Joel",
      "last_name": "Sussman",
      "permalink": "joel-sussman-2",
      "image": null}},
   {"is_past": false,
    "title": "Executive Chairman",
    "person":
     {"first_name": "Craig",
      "last_name": "A. Rosen",
      "permalink": "craig-a-rosen",
      "image": null}},
   {"is_past": true,
    "title": "CFO",
    "person":
     {"first_name": "Thomas",
      "last_name": "Laundon",
      "permalink": "thomas-laundon",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$54.6M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.finsmes.com/2010/01/phasebio-pharmaceuticals-raises.html",
    "source_description": "PhaseBio Pharmaceuticals Raises $25M in Series B Funding Round",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OSI Pharmaceuticals",
         "permalink": "osi-investment-management",
         "image":
          {"available_sizes":
            [[[150,
               16],
              "assets/images/resized/0007/3195/73195v1-max-150x150.png"],
             [[250,
               26],
              "assets/images/resized/0007/3195/73195v1-max-250x250.png"],
             [[289,
               31],
              "assets/images/resized/0007/3195/73195v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hatteras Venture Partners",
         "permalink": "hatteras-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/6917/46917v2-max-150x150.png"],
             [[250,
               65],
              "assets/images/resized/0004/6917/46917v2-max-250x250.png"],
             [[393,
               103],
              "assets/images/resized/0004/6917/46917v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fletcher Spaght Ventures",
         "permalink": "fletcher-spaght-ventures",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0010/2158/102158v2-max-150x150.png"],
             [[250,
               37],
              "assets/images/resized/0010/2158/102158v2-max-250x250.png"],
             [[370,
               55],
              "assets/images/resized/0010/2158/102158v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://olv.duke.edu/About/News/20071025085536830",
    "source_description": "Phase Bioscience raises $6.6 million",
    "raised_amount": 6600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 10,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Fletcher Spaght Ventures",
         "permalink": "fletcher-spaght-ventures",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0010/2158/102158v2-max-150x150.png"],
             [[250,
               37],
              "assets/images/resized/0010/2158/102158v2-max-250x250.png"],
             [[370,
               55],
              "assets/images/resized/0010/2158/102158v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hatteras Venture Partners",
         "permalink": "hatteras-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/6917/46917v2-max-150x150.png"],
             [[250,
               65],
              "assets/images/resized/0004/6917/46917v2-max-250x250.png"],
             [[393,
               103],
              "assets/images/resized/0004/6917/46917v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120605e865tt70p\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120605e865tt70p%26from%3dalert%26pid%3d32",
    "source_description": "PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B ",
    "raised_amount": 23000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 6,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Astellas Venture Management",
         "permalink": "astellas-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6637/46637v3-max-150x150.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-250x250.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fletcher Spaght Ventures",
         "permalink": "fletcher-spaght-ventures",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0010/2158/102158v2-max-150x150.png"],
             [[250,
               37],
              "assets/images/resized/0010/2158/102158v2-max-250x250.png"],
             [[370,
               55],
              "assets/images/resized/0010/2158/102158v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hatteras Venture Partners",
         "permalink": "hatteras-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/6917/46917v2-max-150x150.png"],
             [[250,
               65],
              "assets/images/resized/0004/6917/46917v2-max-250x250.png"],
             [[393,
               103],
              "assets/images/resized/0004/6917/46917v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1 Great Valley Parkway",
    "address2": "Suite 30",
    "zip_code": "19355",
    "city": "Malvern",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/2628/72628v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/2628/72628v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/2628/72628v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}